94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Abdul Muktadir Shafi1
Ákos Végvári2,3
Shanshan Wu Howland4
Roman A. Zubarev3
Laurent Rénia4,5,6
Carlos Penha-Gonçalves1*- 1Disease Genetics, Instituto Gulbenkian de Ciência, Oeiras, Portugal
- 2Proteomics Biomedicum, Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- 3Division of Physiological Chemistry I, Department of Medical Biochemistry and Biophysics, Karolinska Institutet, Stockholm, Sweden
- 4Singapore Immunology Network, Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore
- 5A*STAR Infectious Diseases Labs, Agency for Science, Technology, and Research (A*STAR), Singapore, Singapore
- 6Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore
by Shafi AM, Végvári Á, Howland SW, Zubarev RA, Rénia L, Penha-Gonçalves C (2023) Front. Immunol. 14:1149107. doi: 10.3389/fimmu.2023.1149107
In the published article, there was an error in the author list, and authors Shanshan Wu Howland and Laurent Rénia were erroneously excluded. The corrected author list appears above.
In the published article, there was an error in the Funding statement as a funding source (SymbNET Genomics and Metabolomics in a Host-Microbe Symbiosis Network) was not included. The correct Funding statement appears below.
Funding
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 952537 (SymbNET Genomics and Metabolomics in a Host-Microbe Symbiosis Network. This work was developed with the support from CONGENTO LISBOA-01-0145-FEDER-022170, co-financed by FCT (Portugal) and Lisboa2020, under the PORTUGAL2020 agreement (European Regional Development Fund).
The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cerebral malaria (CM), type - 1 interferons, antigen presentation, endothelial cells, glucose metabolic alterations, proteome, metabolome, malaria
Citation: Shafi AM, Végvári Á, Howland SW, Zubarev RA, Rénia L and Penha-Gonçalves C (2023) Corrigendum: Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism. Front. Immunol. 14:1331366. doi: 10.3389/fimmu.2023.1331366
Received: 01 November 2023; Accepted: 13 November 2023;
Published: 28 November 2023.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2023 Shafi, Végvári, Howland, Zubarev, Rénia and Penha-Gonçalves. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Carlos Penha-Gonçalves, Y3BlbmhhQGlnYy5ndWxiZW5raWFuLnB0